SMTL ID : 4kfz.1 (3 other biounits)

Crystal structure of LMO2 and anti-LMO2 VH complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-mer

Ligands

4 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.22, C.25, H.43, C.46 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.22, A:C.25, A:H.43, A:C.46 ZN.2: 6 residues within 4Å: Chain A: C.49, C.52, C.54, C.72, D.75 Chain B: S.108 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.49, A:C.52, A:C.72, A:D.75 ZN.3: 4 residues within 4Å: Chain A: C.86, C.89, H.108, C.111 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.86, A:C.89, A:H.108, A:C.111 ZN.4: 5 residues within 4Å: Chain A: C.114, C.117, C.136, Q.138, D.139 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.114, A:C.117, A:C.136, A:D.139

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sewell, H. et al., Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex. Sci Rep (2014)

Release Date

2014-01-22

Peptides

LMO-2: A
Anti-LMO2 VH: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

LMO-2

Anti-LMO2 VH

Related Entries With Identical Sequence